Planned UK clinical ADHD support
Planned ADHD medication review and titration support for UK adults.
Work Wise ADHD is building a planned UK private ADHD medication review, titration and monitoring service for eligible adults who already have an ADHD diagnosis.
This service is planned, not currently available. It remains subject to CQC registration, appropriate governance and individual clinical suitability.
The aim is to explain the clinical ADHD support route clearly before anyone starts. That includes what documents may be needed, what prescribing safety checks may be requested, what the service cannot offer, and why medication decisions must be careful and individual.
Joining an update list does not guarantee eligibility, an appointment, medication, shared care or any particular outcome.
Last reviewed: 8 June 2026.
Who it may suit
Adults aged 18 and over who already have a formal ADHD diagnosis from the NHS, Right to Choose, or an appropriately qualified private provider.
What happens first
Documents, health information, monitoring needs and suitability would be checked before any medication appointment or prescribing decision.
What is not offered
The planned service is not an ADHD assessment, emergency service, therapy service, coaching service or guarantee of medication.
How it would work
Clear steps before clinical care begins
The route is structured so eligibility, safety and expectations are clear before any prescribing decision is considered.
1
Join clinical updates
Register your interest and get updates when registration, fees and availability are confirmed.
2
Share key documents
Existing ADHD diagnosis documents and relevant background information would be checked first.
3
Safety information
Medication history, physical health, monitoring needs and possible risks would be reviewed.
4
Appointment if suitable
If the service opens and it looks like the right route, an appointment may be offered.
5
Medication changes if appropriate
Titration, prescribing and monitoring would only happen if the service is registered and it is clinically appropriate.
6
Review and next steps
Medication decisions would be cautious, individual and based on the information available.
Boundaries before joining
- No ADHD diagnostic assessments
- No second opinions on disputed diagnoses
- No crisis or emergency support
- No therapy, counselling, or coaching
- No guaranteed medication
- No guaranteed shared care
- No active prescribing or titration until appropriately registered
Private prescriptions
If prescribing becomes available, prescriptions would be private prescriptions. Patients would pay the pharmacy for medication. NHS shared care would not be required, relied on, or guaranteed.
The service is being developed from England for eligible adults in the UK. It would still depend on regulatory, prescribing, governance and location-specific requirements.
Designed for clarity
No vague promises. No rushed medication decisions.
The planned service is being shaped around careful documents, health checks, monitoring, clear communication and realistic expectations before any medication decision is considered.
Want updates when the planned pathway opens?
Join clinical pathway updates for non-urgent information. This does not guarantee eligibility, an appointment, medication, shared care or a specific outcome.